Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728.SZ

17.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009
Revenue 1,054.931886.571758.16632.695921.122884.976686.944655.857516.54344.748342.721340.827305.131250.808202.139
Cost of Revenue 496.538451.833356.076327.088374.504363.842355.743342.735282.662192.398193.791198.75183.679163.56151.392
Gross Profit 558.394434.738402.085305.608546.618521.134331.201313.121233.879152.35148.93142.077121.45387.24750.747
Gross Profit Ratio 0.5290.490.530.4830.5930.5890.4820.4770.4530.4420.4350.4170.3980.3480.251
Reseach & Development Expenses 39.02838.0137.77736.49944.38346.62646.16350.80626.34317.11416.28315.3713.97800
General & Administrative Expenses 13.3099.69612.94713.95718.57519.98513.31614.03120.6687.0115.0164.4384.38917.2214.216
Selling & Marketing Expenses 174.359117.399118.73598.917205.594200.07103.01189.68274.36535.89328.20124.79518.40314.2526.649
SG&A 216.194127.095131.682112.875224.168220.055116.327103.71495.03342.90433.21729.23222.79231.47220.865
Other Expenses 3.45650.60949.54546.01340.637-4.763.6595.5423.52-3.889-2.7671.1393.9052.350.817
Operating Expenses 251.767215.714219.004195.387309.188307.801197.729194.951141.99770.2758.47353.73644.62532.90221.73
Operating Income 306.627196.548201.428121.741197.576181.915115.954100.43891.76890.30193.26888.28277.01453.52827.177
Operating Income Ratio 0.2910.2220.2660.1920.2140.2060.1690.1530.1780.2620.2720.2590.2520.2130.134
Total Other Income Expenses Net -13.633-0.223-54.329-68.463-0.717-36.177-13.859-12.7753.3710.9463.013.0754.191.532-1.023
Income Before Tax 292.994196.325147.09953.278196.86177.156119.613105.39695.25293.02693.46791.41681.01855.87727.994
Income Before Tax Ratio 0.2780.2210.1940.0840.2140.20.1740.1610.1840.270.2730.2680.2660.2230.138
Income Tax Expense 39.81818.12120.1829.46225.14921.60913.2710.61914.14712.83212.91212.83711.3237.8933.894
Net Income 253.176178.204126.91743.816171.71155.546106.34394.77781.10580.19480.55578.57869.69547.98524.1
Net Income Ratio 0.240.2010.1670.0690.1860.1760.1550.1450.1570.2330.2350.2310.2280.1910.119
EPS 0.770.570.410.150.610.560.380.340.290.340.380.380.330.240.13
EPS Diluted 0.770.570.410.150.60.560.380.340.290.340.380.380.330.240.13
EBITDA 366.802279.41252.734172.771288.842263.206173.753156.432114.79390.017100.805100.38187.98660.72535.394
EBITDA Ratio 0.3480.3150.3330.2730.3140.2970.2530.2390.2220.2610.2940.2950.2880.2420.175